Tag: FDA CHI

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsFDA CHI

InventHelp Inventor Develops New Dust Management System (TLS-837)

FortisBC to issue call for power to help meet energy demand in the Southern Interior

European savings and retirement services group Athora to acquire Pension Insurance Corporation Group

Tag: FDA CHI

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us